Jump to content

Vilazodone: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
Auto-created stub
 
Expand stub to full MedTemplate parameter set
Line 1: Line 1:
{{MedTemplate
{{MedTemplate
| generic           = Vilazodone
| generic           = Vilazodone
| brand             = Viibryd
| brand             = Viibryd
| classes           = SSRI, Antidepressant
| structure          =
| mechanism         = SSRI and 5-HT1A partial agonist
| classes           = SSRI, Antidepressant
| mechanism         = SSRI and 5-HT1A partial agonist
| uses              =
| starting_dose      =
| preparations      =
| routes            =
| onset              =
| duration          =
| halflife          =
| bioavailability    =
| pregnancy          =
| legal              =
| intro              =
| pharmacokinetics  =
| pharmacodynamics  =
| indications        =
| dosing            =
| effects            =
| contraindications  =
| interactions      =
| pregnancy_details  =
| monitoring        =
| counseling        =
| anecdotes          =
| seealso            =
| references        =
}}
}}
[[Category:Antidepressants]]
[[Category:Antidepressants]]



Revision as of 01:00, 13 May 2026

SSRI, Antidepressant
Vilazodone
Viibryd

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
SSRI, Antidepressant
Common uses
Pharmacy
Pharmacology
Purported mechanism
SSRI and 5-HT1A partial agonist